The Glaucoma Italian Pediatric Study (GIPSy): 3-Year Results

Luciano Quaranta, Elena Biagioli, Ivano Riva, Francesca Galli, Davide Poli, Eliana Rulli, Andreas Katsanos, Antonio Longo, Maurizio G Uva, Francesco Oddone, Valter Torri, Robert N Weinreb

Research output: Contribution to journalArticle

Abstract

PURPOSE: To investigate the efficacy and safety of a treatment strategy with latanoprost and dorzolamide in primary pediatric glaucoma patients partially responsive to surgery.PATIENTS AND METHODS: Children with primary pediatric glaucoma with postsurgical intraocular pressure (IOP) between 22 and 26 mm Hg were eligible. At baseline, patients were administered latanoprost once daily. Depending on IOP reduction, patients were allocated to continuation of latanoprost monotherapy or addition of dorzolamide twice daily, or switch to dorzolamide monotherapy 3 times daily. Patients in the dorzolamide monotherapy group with IOP reduction
Original languageItalian
Pages (from-to)856-863
Number of pages8
JournalJournal of Glaucoma
Volume27
Issue number10
DOIs
Publication statusPublished - Oct 2018

Cite this

The Glaucoma Italian Pediatric Study (GIPSy): 3-Year Results. / Quaranta, Luciano; Biagioli, Elena; Riva, Ivano; Galli, Francesca; Poli, Davide; Rulli, Eliana; Katsanos, Andreas; Longo, Antonio; Uva, Maurizio G; Oddone, Francesco; Torri, Valter; Weinreb, Robert N.

In: Journal of Glaucoma, Vol. 27, No. 10, 10.2018, p. 856-863.

Research output: Contribution to journalArticle

Quaranta, L, Biagioli, E, Riva, I, Galli, F, Poli, D, Rulli, E, Katsanos, A, Longo, A, Uva, MG, Oddone, F, Torri, V & Weinreb, RN 2018, 'The Glaucoma Italian Pediatric Study (GIPSy): 3-Year Results', Journal of Glaucoma, vol. 27, no. 10, pp. 856-863. https://doi.org/10.1097/IJG.0000000000001038
Quaranta, Luciano ; Biagioli, Elena ; Riva, Ivano ; Galli, Francesca ; Poli, Davide ; Rulli, Eliana ; Katsanos, Andreas ; Longo, Antonio ; Uva, Maurizio G ; Oddone, Francesco ; Torri, Valter ; Weinreb, Robert N. / The Glaucoma Italian Pediatric Study (GIPSy): 3-Year Results. In: Journal of Glaucoma. 2018 ; Vol. 27, No. 10. pp. 856-863.
@article{4f1717e184244f44a56f0a80d9b4cc3e,
title = "The Glaucoma Italian Pediatric Study (GIPSy): 3-Year Results",
abstract = "PURPOSE: To investigate the efficacy and safety of a treatment strategy with latanoprost and dorzolamide in primary pediatric glaucoma patients partially responsive to surgery.PATIENTS AND METHODS: Children with primary pediatric glaucoma with postsurgical intraocular pressure (IOP) between 22 and 26 mm Hg were eligible. At baseline, patients were administered latanoprost once daily. Depending on IOP reduction, patients were allocated to continuation of latanoprost monotherapy or addition of dorzolamide twice daily, or switch to dorzolamide monotherapy 3 times daily. Patients in the dorzolamide monotherapy group with IOP reduction",
author = "Luciano Quaranta and Elena Biagioli and Ivano Riva and Francesca Galli and Davide Poli and Eliana Rulli and Andreas Katsanos and Antonio Longo and Uva, {Maurizio G} and Francesco Oddone and Valter Torri and Weinreb, {Robert N}",
year = "2018",
month = "10",
doi = "10.1097/IJG.0000000000001038",
language = "Italian",
volume = "27",
pages = "856--863",
journal = "Journal of Glaucoma",
issn = "1057-0829",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - The Glaucoma Italian Pediatric Study (GIPSy): 3-Year Results

AU - Quaranta, Luciano

AU - Biagioli, Elena

AU - Riva, Ivano

AU - Galli, Francesca

AU - Poli, Davide

AU - Rulli, Eliana

AU - Katsanos, Andreas

AU - Longo, Antonio

AU - Uva, Maurizio G

AU - Oddone, Francesco

AU - Torri, Valter

AU - Weinreb, Robert N

PY - 2018/10

Y1 - 2018/10

N2 - PURPOSE: To investigate the efficacy and safety of a treatment strategy with latanoprost and dorzolamide in primary pediatric glaucoma patients partially responsive to surgery.PATIENTS AND METHODS: Children with primary pediatric glaucoma with postsurgical intraocular pressure (IOP) between 22 and 26 mm Hg were eligible. At baseline, patients were administered latanoprost once daily. Depending on IOP reduction, patients were allocated to continuation of latanoprost monotherapy or addition of dorzolamide twice daily, or switch to dorzolamide monotherapy 3 times daily. Patients in the dorzolamide monotherapy group with IOP reduction

AB - PURPOSE: To investigate the efficacy and safety of a treatment strategy with latanoprost and dorzolamide in primary pediatric glaucoma patients partially responsive to surgery.PATIENTS AND METHODS: Children with primary pediatric glaucoma with postsurgical intraocular pressure (IOP) between 22 and 26 mm Hg were eligible. At baseline, patients were administered latanoprost once daily. Depending on IOP reduction, patients were allocated to continuation of latanoprost monotherapy or addition of dorzolamide twice daily, or switch to dorzolamide monotherapy 3 times daily. Patients in the dorzolamide monotherapy group with IOP reduction

U2 - 10.1097/IJG.0000000000001038

DO - 10.1097/IJG.0000000000001038

M3 - Articolo

VL - 27

SP - 856

EP - 863

JO - Journal of Glaucoma

JF - Journal of Glaucoma

SN - 1057-0829

IS - 10

ER -